Glesby | HIV and Cardiovascular Risk | Buch | 978-0-19-973730-7 | sack.de

Buch, Englisch, 80 Seiten, Format (B × H): 168 mm x 168 mm, Gewicht: 77 g

Reihe: Oxford American Pocket Notes

Glesby

HIV and Cardiovascular Risk

Buch, Englisch, 80 Seiten, Format (B × H): 168 mm x 168 mm, Gewicht: 77 g

Reihe: Oxford American Pocket Notes

ISBN: 978-0-19-973730-7
Verlag: Hurst & Co.


Advances in antiretroviral therapy have led to the expectation that many people living with HIV infection will live for decades. The demographics of the HIV epidemic in the developed world have also shifted in recent years, making older adults an increasing proportion of patients. As a consequence, cardiovascular disease, the major cause of mortality in the general population, has become an important long-term concern in the HIV-infected population as well.
Furthermore, there is increasing recognition that HIV and antiretroviral-related factors may contribute to accelerated atherosclerosis in this population. Taken together, these factors suggest that the prevalence of cardiovascular disease in HIV-infected patients will continue to grow in the coming years.
There is increasing demand for up-to-date knowledge in the area of cardiovascular disease in HIV-infected patients. The proposed book, HIV and Cardiovascular Risk (Oxford American Pocket Notes), will target both HIV care-providers and cardiologists who regularly treat HIV-infected patients. HIV care-providers must stay current with cardiac issues that affect their patients, and cardiologists must be aware of HIV-specific factors, including drug-drug interactions between cardiac drugs and
antiretrovirals, to provide optimal care to these patients.
Part of the Oxford American Pocket Note series, this ultra concise handbook covers the full spectrum of cardiovascular disease in HIV-infected patients, but also discusses each topic in proportion to its clinical importance. As such, the majority of the book will be devoted to coronary heart disease risk. Other clinically important cardiac conditions are also addressed, including cardiomyopathy, pericardial effusion, endocarditis, pulmonary hypertension, cardiac tumors, and conduction
abnormalities. Using the most up-to-date material available, this guide provides ID specialists, cardiologists and other clinicians with an invaluable evidence-based resource in the proper assessment and management of cardiovascular risks in HIV patients. The portable volume includes evidence-based
clinical guidance on the latest diagnostic guidelines, laboratory evaluations and cognitive testing for these prevalent disorders. Outstanding features include numerous illustrations of key concepts and pathways as well as summary tables and charts.
Glesby HIV and Cardiovascular Risk jetzt bestellen!

Zielgruppe


Ideal for infectious diseases specialists, cardiologists, general practitioners and other healthcare providers.


Autoren/Hrsg.


Weitere Infos & Material


Marshall J. Glesby, MD, PhD
Associate Professor of Medicine and Public Health
Clinical Trials Unit, Division of International Medicine and Infectious Diseases
Weill Medical College of Cornell University
New York


Ihre Fragen, Wünsche oder Anmerkungen
Vorname*
Nachname*
Ihre E-Mail-Adresse*
Kundennr.
Ihre Nachricht*
Lediglich mit * gekennzeichnete Felder sind Pflichtfelder.
Wenn Sie die im Kontaktformular eingegebenen Daten durch Klick auf den nachfolgenden Button übersenden, erklären Sie sich damit einverstanden, dass wir Ihr Angaben für die Beantwortung Ihrer Anfrage verwenden. Selbstverständlich werden Ihre Daten vertraulich behandelt und nicht an Dritte weitergegeben. Sie können der Verwendung Ihrer Daten jederzeit widersprechen. Das Datenhandling bei Sack Fachmedien erklären wir Ihnen in unserer Datenschutzerklärung.